Usona in the News
Parting the Clouds
Charles Raison On New Treatments For Depression
January 29, 2021 | The Sun MagazineUpdates
Usona Statement on Phase 3 Study of Psilocybin for Major Depressive Disorder (MDD) (uAspire)
March 20, 2024
Usona Institute Research Unveils New Compounds with Observed Psychedelic-like Activity
January 10, 2024
Usona statement on JAMA publication of PSIL201 data
August 31, 2023
Media Inquiries
MEDIA REQUESTMedia Inquiries
Please contact mediarequests@usonainstitute.org with the following information:
- Name and organization
- Description of what you would like to cover
- Deadline